515
Participants
Start Date
March 12, 2013
Primary Completion Date
April 14, 2014
Study Completion Date
May 9, 2014
Etelcalcetide
Administered intravenously three times per week. The starting dose was 5 mg. The dose may have been increased at weeks 5, 9, 13, and 17 (4-week intervals) by 2.5 mg or 5 mg on the basis of the predialysis parathyroid hormone and corrected calcium concentrations obtained in the prior week. The minimum dose was 2.5 mg and the maximum dose was 15 mg.
Placebo
Administered intravenously (IV) three times per week.
Research Site, Budapest
Research Site, Brussels
Research Site, Budapest
Research Site, Brussels
Research Site, Westmead
Research Site, Esztergom
Research Site, Bonheiden
Research Site, Clayton
Research Site, Miskolc
Research Site, Liège
Research Site, Brisbane
Research Site, Adelaide
Research Site, Kecskemét
Research Site, Tournai
Research Site, Roeselare
Research Site, Zalaegerszeg
Research Site, Great Neck
Research Site, Brooklyn
Research Site, Fresh Meadows
Research Site, Marseille
Research Site, Marseille
Research Site, Caen
Research Site, Córdoba
Research Site, Granada
Research Site, Milan
Research Site, Ft. Washington
Research Site, Bethesda
Research Site, Alexandria
Research Site, Lecco
Research Site, Charlotte
Research Site, Majadahonda
Research Site, New Bern
Research Site, Columbia
Research Site, Augusta
Research Site, Macon
Research Site, Bordeaux
Research Site, Miami
Research Site, Lauderdale Lakes
Research Site, Ocala
Research Site, Mobile
Research Site, Chattanooga
Research Site, Knoxville
Research Site, Grenoble
Research Site, Brookhaven
Research Site, Kfar Saba
Research Site, Cincinnati
Research Site, Merrillville
Research Site, Detroit
Research Site, Tel Litwinsky
Research Site, Gurnee
Research Site, Ancona
Research Site, Chicago
Research Site, Perpignan
Research Site, Lincoln
Research Site, Ẕerifin
Research Site, Shreveport
Research Site, Arlington
Research Site, Houston
Research Site, Lubbock
Research Site, Denver
Research Site, Las Vegas
Research Site, Los Angeles
Research Site, Beverly Hills
Research Site, Norwalk
Research Site, Jerusalem
Research Site, Glendale
Research Site, Northridge
Research Site, Azusa
Research Site, Chula Vista
Research Site, Riverside
Research Site, Simi Valley
Research Site, Fairfield
Research Site, Erfurt
Research Site, Moscow
Research Site, Yaroslavl
Research Site, Saint Petersburg
Research Site, Stamford
Research Site, Wichita
Research Site, Eatontown
Research Site, Rutland
Research Site, Morgantown
Research Site, Edmonton
Research Site, New Westminster
Research Site, Halifax
Research Site, Toronto
Research Site, Montreal
Research Site, Nový Jičín
Research Site, Pilsen
Research Site, Prague
Research Site, Ústí nad Orlicí
Research Site, Quartu Sant'Elena CA
Research Site, Amsterdam
Research Site, Enschede
Research Site, Rotterdam
Research Site, Venlo
Research Site, Gdansk
Research Site, Golub-Dobrzyń
Research Site, Krakow
Research Site, Lodz
Research Site, Rybnik
Research Site, Warsaw
Research Site, Barcelona
Research Site, Barcelona
Research Site, Karlstad
Research Site, Stockholm
Research Site, Uppsala
Lead Sponsor
Amgen
INDUSTRY